CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-July
2025-April

ASC Fee Schedule

2025-July
2025-April

APC Codes

2025-July
2025-April

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-July
2025-April


CMS Transmittals



.


CodeMap® Compliance Briefing: 9/21/07


Editor's Welcome:

Recently, the press has covered the increasing incidence of hospital borne infections caused by, "superbugs," or bacteria that is resistant to conventional antibiotics. Following the press coverage, a handful of state legislatures have debated and/or passed legislation to help combat these costly, and sometimes deadly infections. In addition, Medicare is now strongly encouraging all providers to take measures to eliminate preventable illnesses by promulgating rules and regulations that disallow reimbursement for many tests and services necessitated by hospital borne infections. Today's briefing will examine the Medicare coding, reimbursement, and coverage implications of superbugs, in particular MRSA.

Sincerely,

Gregory Root, Esq.


Coding and Medicare Reimbursement for MRSA Tests

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.